The global landscape of manufacturing and vaccine delivery is undergoing rapid transformation. Focusing on the unique challenges and innovations shaping the global health landscape, this webinar draws on the evolving concept of “access” in vaccine delivery in both high- and low-income countries.
The webinar will delve into critical considerations for improving global vaccine and healthcare delivery and outcomes. This session will also explore cutting-edge strategies to optimize distributed manufacturing systems, focusing on reducing operational costs while ensuring flexibility and safety across decentralized production sites.
The role of the blow-fill-seal (BFS) prefilled drug delivery platform in expanding vaccine access will also be highlighted as a transformative solution. Participants will learn how the BFS prefilled drug delivery platform can improve access, streamline logistics and reduce costs for decentralized manufacturing locations.
Special emphasis will be placed on reducing the carbon footprint of fill-finish operations in the pharmaceutical industry through environmental assessments and the adoption of innovative technologies, supported by an environmental study.
Register for this webinar to gain insights into how the blow-fill-seal prefilled drug delivery platform can transform vaccine logistics and enhance global healthcare outcomes.
Speakers
Ed Kelley, PhD, Chief Global Health Officer, Apiject Systems; Former Director, Service Delivery and Safety, World Health Organization
Dr. Ed Kelley serves as ChiefGlobal Health Officer for ApiJect Systems, a US-based public benefit company whose mission is to make vaccines and injectable medicines safe and affordable for everyone. In this role, Dr. Kelley leads work on a range of global health projects from COVID-19 and routine vaccine deployment to injectable contraception and injectable HIV pre-exposure prophylaxsis (PrEP). He leads Apiject’s engagement with global health partners such as WHO, UNICEF, The Global Fund and GAVI to address vaccine and medicine systems issues from production to supply chain to front-line delivery.
Read more...
Prior to his current role, Dr Kelley was Director of Integrated Health Systems for the World Health Organization, with active program in clinical services, health systems policy and services regulation, patient safety and quality of care and health services performance monitoring. He led work on integrating immunization into primary care and was WHO’s lead on ensuring continuity of essential health services during COVID for both the WHO COVID-19 Response Plan and the UN Secretary General’s Socioeconomic Response Plan for COVID-19.
Prior to joining WHO, Dr. Kelley served as Director of the US National Healthcare Reports for the US Department of Health and Human Services in the Agency for Healthcare Research and Quality reporting to the Secretary for HHS and the US Congress. Dr Kelley also directed the 28-country Health Care Quality Improvement (HCQI) Project of the Organization of Economic Cooperation and Development and served as a Senior Researcher and Quality Assurance Advisor for USAID as part of two large initiatives. He has worked and lived in West and North Africa, Latin America and the Western Pacific region.
Read Less...
Orin Levine, PhD, Fellow, Center for Global Development, Board of Trustees, Sabin Vaccine Institute; Former Director, Global Delivery Programs, Bill and Melinda Gates Foundation
Dr. Orin Levine is a highly experienced mission driven executive leader and public health expert who is passionate about combining innovation with dogged execution and using advocacy based on evidence to reduce health inequities around the world. Over the past 30 years, Orin has successfully worked to accelerate the introduction of and access to vaccines and other proven health interventions in low- and middle-income countries. His experience includes years of service on global boards, including Gavi, leading large and small teams, and engaging with senior executives to achieve impact.
Read more...
Orin’s notable contributions to expanding vaccine access and improving health equity include leading the effort to establish the first ever Advance Market Commitment (AMC). As the Executive Director of GAVI’s Pneumococcal Vaccines Accelerated Development and Introduction Program (PneumoADIP), Orin led the overall program combining skills in epidemiology, management, industry relations, and communications & advocacy. The PneumoADIP team influenced global policies including the WHO recommendation that all countries should introduce pneumococcal conjugate vaccines and most notably, developed the successful “investment case” that led donors to commit >$1.5 billion for the procurement of pneumococcal vaccines for children.
As a Gavi Board member representing the Bill & Melinda Gates Foundation for nearly 9 years, Orin brings a strong understanding of the dynamics of Gavi with countries, donors and industry. During his time on the Board Orin contributed to the establishment of the COVAX AMC and served on the Executive Committee, the Governance Committee and the Market Sensitive Decisions Committee that provided recommendations on specific industry deals.
Read Less...
Who Should Attend?
This webinar will appeal to professionals in the following fields or those with the following titles:
- Access/Drug Delivery/Epidemiology
- Global Health/Global Medical/Global Program
- Market Access/Medical Affairs
- New Product/Parenterals
- Portfolio/Procurement
- Product Development
- Strategy/Vaccine(s)
- Portfolio Program
What You Will Learn
Attendees will learn about:
- The core challenges for the immunization community in reaching underserved populations for routine immunizations and outbreak response across diverse regions
- How understanding the needs of users, manufacturers and healthcare providers is essential to sustaining market presence and how a user-centered approach to design, prototyping and production can be a market advantage
- How a BFS prefilled drug delivery platform can broaden access, improve logistics and reduce cost across decentralized manufacturing locations
- Solutions and technologies that are eco-friendly and minimize carbon footprint via an environmental study
Xtalks Partner
ApiJect Systems
ApiJect Systems, Corp. is a public-benefit medical technology company that has pioneered a new category of prefilled injection devices with economic, supply chain, and sustainability advantages over traditional offerings. Our mission is to make the safety and performance benefits of prefilled injections affordable and available for most, if not all, injections around the world. The Company’s technology platform is anchored by a well-established manufacturing process called Blow-Fill-Seal (BFS”). BFS is a widely used sterile liquid packaging technology that has been recognized by the FDA as an advanced aseptic process.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account